ANTISETTINI S COLL

ANTISETTINI ASTRINGENTE SEDATIVE COLLIRIA, SOLUTION

active ingredients

100 ml contain. Active ingredients: Zinc sulphonate g 0.500, sulfacetamide sodium g 3, nafazoline hydrochloride g 0.005, lidocaine hydrochloride g 0.750. Excipients with known effects: mertiolate sodium, benzoic esters (methyl-p-hydroxybenzoate and propyl-p-hydroxybenzoate) For the full list of excipients, see paragraph 6.1.

Excellent

Chloride ammonium, p-oxybenzoic esters, mertiolate sodium, purified water.

Therapeutic indications

Therapy of simple joints.

Contraindications

Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1verso the product components. Antiseptic Astringente Sedativo is contraindicated in children under the age of 6.

Population

Istillate 1 drop, two or more times a day, in the lower joint furnace. After the distillation keep the eye closed for a few moments. Strictly stick to the recommended doses. A higher dose of the product even if taken in a topical way and for a short period of time can give rise to serious systemic effects.

Conservation

Store at temperature not exceeding 30°C. The product should not be used over 30 days after the first opening of the container.

Warnings

Do not exceed the doses indicated. Do not administer for more than seven consecutive days without consulting your doctor. Pediatric population Do not administer children under the age of six. If sensitization phenomena occur interrupt treatment and establish suitable therapy. Antiseptic Astringent Sedative contains mertiolate sodium: it can cause allergic reactions. Antiseptic Astringent Sedative contains benzoic hydroxes (methyl-p-hydroxybenzoate and propil-p-hydroxybenzoate) that can cause allergic reactions (also delayed).

Interactions

They're not known.

Effects

No undesirable side effects were reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

Due to poor systemic absorption, the effects of overdose are extremely rareri with the exception of accidental ingestion cases. If this happens to practice symptomatic therapy.

pregnancy and nursing . In pregnant women established or presumed and during the breastfeeding period, the product should be administered in case of actual need, according to the advice of the doctor.

Source: Farmadati